ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells <i>in vitro</i>

Dandan Yu(Union Hospital), Zhenhe Suo(Oslo University Hospital), Jing Cao(Rutgers, The State University of New Jersey), Gunnar Kvalheim(Oslo University Hospital), Yuan Yuan(Hebei University of Technology), Mingzhi Zhang(Soochow University), Xiaoli Li(Fujian Medical University), Huijie Fan(Shanxi University), Jianguo Wen(Argonne National Laboratory), Xiaoran Li(Shanghai Jiao Tong University), Yaqing Li(Sun Yat-sen University), Zhenyu Ji(Bengbu Medical College), Jahn M. Nesland(Oslo University Hospital), Yali Zhong(Oslo University Hospital), Baoping Qiao(First Affiliated Hospital of Zhengzhou University)
Oncotarget
October 21, 2015
Cited by 24


Related Papers